Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Intrathecal Spartaject-Busulfan in Children With Neoplastic Meningitis

NCT00006246 is registered in ClinicalTrials.gov with Pediatric Brain Tumor Consortium as lead sponsor.

NCT NCT00006246
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00006246 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Intrathecal Spartaject-Busulfan in Children With Neoplastic Meningitis
Lead sponsor
Pediatric Brain Tumor Consortium
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2000
Completion date
Not reported
Enrollment
28 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors, childhood germ cell tumor, leukemia, lymphoma, metastatic cancer, retinoblastoma, sarcoma